Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.4.2.30 (
PARP
)
13,611
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Polycomb group (PcG) proteins are involved in epigenetic silencing where they function as major determinants of cell identity, stem cell pluripotency and the epigenetic gene silencing involved in cancer development. Recently numerous PcG proteins, including
CBX4
, have been shown to accumulate at sites of DNA damage. However, it remains unclear whether or not
CBX4
or its E3 sumo ligase activity is directly involved in the DNA damage response (DDR). Here we define a novel role for
CBX4
as an early DDR protein that mediates SUMO conjugation at sites of DNA lesions. DNA damage stimulates sumoylation of BMI1 by
CBX4
at lysine 88, which is required for the accumulation of BMI1 at DNA damage sites. Moreover, we establish that
CBX4
recruitment to the sites of laser micro-irradiation-induced DNA damage requires
PARP
activity but does not require H2AX, RNF8, BMI1 nor PI-3-related kinases. The importance of
CBX4
in the DDR was confirmed by the depletion of
CBX4
, which resulted in decreased cellular resistance to ionizing radiation. Our results reveal a direct role for
CBX4
in the DDR pathway.
...
PMID:CBX4-mediated SUMO modification regulates BMI1 recruitment at sites of DNA damage. 2240 92